Charles Welliver1, Lydia Feinstein2, Julia B Ward2, Chyng-Wen Fwu2, Ziya Kirkali3, Tamara Bavendam3, Brian R Matlaga4, Kevin T McVary5. 1. Division of Urology, Albany Medical College, Albany, New York. 2. Social and Scientific Systems, Durham, North Carolina. 3. National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda, Maryland. 4. Departments of Urology, James Buchanan Brady Urological Institute, Johns Hopkins University School of Medicine, Baltimore, Maryland. 5. Loyola University Medical Center, Maywood, Illinois.
Abstract
PURPOSE: Our current understanding of recent trends in the management of lower urinary tract symptoms associated with benign prostatic hyperplasia is incomplete, particularly in younger men. The 2018 Urologic Diseases in America Project attempted to fill this gap by analyzing multiple large administrative claims databases which include men of all ages and permit longitudinal followup. To our knowledge we report these findings for the first time in the scientific literature. MATERIALS AND METHODS: The 2 data sources used in this study included the de-identified Optum® Clinformatics® Data Mart database for men 40 to 64 years old and the Medicare 5% Sample for men 65 years old or older. To assess trends in lower urinary tract symptoms/benign prostatic hyperplasia related medication prescriptions and surgical procedures from 2004 to 2013 we created annual cross-sectional cohorts and a longitudinal cohort of patients with incident lower urinary tract symptoms/benign prostatic hyperplasia and 5 years of followup. RESULTS: The use of medications related to lower urinary tract symptoms/benign prostatic hyperplasia increased with age, particularly among men 40 to 60 years old. While medication use increased with time, surgical procedures decreased. Increasing age correlated with a higher rate of surgical procedures in the longitudinal cohort. Younger men were more likely to elect treatments of lower urinary tract symptoms/benign prostatic hyperplasia which reportedly optimize sexual function. CONCLUSIONS: Medication use increased and surgery decreased during the study period. Treatment approaches to lower urinary tract symptoms/benign prostatic hyperplasia varied greatly by patient age. While the minority of men in the fifth and sixth decades of life required treatment, a sharp increase in treatment use was seen between these decades. Younger men were more likely to elect less invasive surgical options. Future studies of lower urinary tract symptoms/benign prostatic hyperplasia should focus on age specific treatment selection.
PURPOSE: Our current understanding of recent trends in the management of lower urinary tract symptoms associated with benign prostatic hyperplasia is incomplete, particularly in younger men. The 2018 Urologic Diseases in America Project attempted to fill this gap by analyzing multiple large administrative claims databases which include men of all ages and permit longitudinal followup. To our knowledge we report these findings for the first time in the scientific literature. MATERIALS AND METHODS: The 2 data sources used in this study included the de-identified Optum® Clinformatics® Data Mart database for men 40 to 64 years old and the Medicare 5% Sample for men 65 years old or older. To assess trends in lower urinary tract symptoms/benign prostatic hyperplasia related medication prescriptions and surgical procedures from 2004 to 2013 we created annual cross-sectional cohorts and a longitudinal cohort of patients with incident lower urinary tract symptoms/benign prostatic hyperplasia and 5 years of followup. RESULTS: The use of medications related to lower urinary tract symptoms/benign prostatic hyperplasia increased with age, particularly among men 40 to 60 years old. While medication use increased with time, surgical procedures decreased. Increasing age correlated with a higher rate of surgical procedures in the longitudinal cohort. Younger men were more likely to elect treatments of lower urinary tract symptoms/benign prostatic hyperplasia which reportedly optimize sexual function. CONCLUSIONS: Medication use increased and surgery decreased during the study period. Treatment approaches to lower urinary tract symptoms/benign prostatic hyperplasia varied greatly by patient age. While the minority of men in the fifth and sixth decades of life required treatment, a sharp increase in treatment use was seen between these decades. Younger men were more likely to elect less invasive surgical options. Future studies of lower urinary tract symptoms/benign prostatic hyperplasia should focus on age specific treatment selection.
Entities:
Keywords:
age groups; drug prescriptions; lower urinary tract symptoms; prostatic hyperplasia; urologic surgical procedures
Authors: Scott R Bauer; Peggy M Cawthon; Kristine E Ensrud; Anne M Suskind; John C Newman; Howard A Fink; Kaiwei Lu; Rebecca Scherzer; Andrew R Hoffman; Kenneth Covinsky; Lynn M Marshall Journal: J Am Geriatr Soc Date: 2021-12-24 Impact factor: 5.562
Authors: Maria M Wertli; Brigitta Zumbrunn; Pascal Weber; Alan G Haynes; Radoslaw Panczak; Arnaud Chiolero; Nicolas Rodondi; Drahomir Aujesky Journal: PLoS One Date: 2021-07-22 Impact factor: 3.240
Authors: Jong Keun Kim; Changil Choi; Ui Seok Kim; Hyosang Kwon; Seong Ho Lee; Young Goo Lee; Jun Hyun Han Journal: J Korean Med Sci Date: 2020-09-28 Impact factor: 2.153
Authors: Larry E Miller; Bilal Chughtai; Kevin McVary; Ricardo R Gonzalez; Sirikan Rojanasarot; Kyle DeRouen; Samir Bhattacharyya Journal: Medicine (Baltimore) Date: 2020-07-24 Impact factor: 1.817